As one of the most preeminent and comprehensive blood centers in theworld, nybc operates under a four-part mission. For more information, and part iii, 4a-c.
Key facts about New York Blood Center Inc
- EIN
- 13-1949477
- Latest 990 filing
- Form 990, 2025
- Total assets
- $865,370,158
Data from IRS Form 990, 2025; updated October 2026.
Financial Overview
From 2025 IRS Form 990 · View filing
Total Assets
$865.4M
-2.2% YoY
Revenue
$629.0M
+3.8% YoY
Net Investment Income
$11.1M
+125.7% YoY
Expenses
$663.4M
+1.6% YoY
About New York Blood Center Inc
Based on IRS filings
New York Blood Center Inc is a public charity focused on Health, based in Rye, NY. IRS filing data is available from 2019 through 2025. As of 2025, the organization holds $865.4M in total assets. Net investment income was $11.1M.
Focus Areas
Open Grants
3 open opportunities from New York Blood Center Inc
Bloodstock® Scholarship Program
New York Blood Center Inc
Amount
Up to $1,000
Deadline
Rolling / Open
High School Scholarship Program
New York Blood Center Inc
Amount
$500 - $2,000
Deadline
Rolling / Open
Little Doctors Program®
New York Blood Center Inc
Amount
Varies
Deadline
Rolling / Open
Ready to take the next step with New York Blood Center Inc?
Geographic Focus
Where this funder awards grants
Grant Distribution by State
States
Cities
Giving Over Time
Total grant dollars and number of grants per year
From 2019 to 2024, annual grant giving ranged from $3K (2022) to $35K (2021, 21 months). In 2024 it reported $8K in grants paid, as a total without an itemized list.
*2021: Covers 21 months (fiscal year-end changed).
Hatched bars: grants paid as reported on the IRS filing, which lists no individual grants for that year.
Grant Insights
How this funder distributes its grants
Grant Size Distribution
2 grants across all recorded years
The most common grant size was under $50K: 2 grants of 2 (100%).
Giving History
Grant recipients and amounts by year
No grants recorded for 2025.
Financial History
Multi-year comparison from IRS filings
*2021: Covers 21 months (fiscal year-end changed).
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Assets | $865,370,158 | $884,660,660 | $784,292,844 |
| Revenue | $629,039,352 | $605,770,964 | $564,818,942 |
| Expenses | $663,407,327 | $652,737,231 | $599,527,174 |
| Net Investment Income | $11,087,554 | $4,911,840 | $-555,884 |
Data update history
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS February 15, 2021)
- Added Form 990 for fiscal year 2019 (received by the IRS February 14, 2020)
- Updated Form 990 for fiscal year 2021 (received by the IRS December 14, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS May 2, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS May 13, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS May 14, 2025)
- Added Form 990 for fiscal year 2025 (received by the IRS May 13, 2026)
- IRS filings on file for fiscal years 2020–2024
Leadership & Key People
Officers and directors from IRS filings
New York Blood Center Inc is led by Christopher D. Hillyer, President & Chief Executive Officer since 2021 (on filings since 2019); 26 of 42 officers listed in 2025 are compensated.
Officers on the 2025 filing
Christopher D. Hillyer
President & Chief Executive Officer
President & CEO → President & Chief Executive Officer, 2021
On filings since 2019
50 hrs/week
$1.7M (2019) → $2.6M (2025)
Aaron R. Marcu
Trustee
On filings since 2019
1 hr/week
No compensation reported
Ariel Fishman
Trustee
On filings since 2019
1 hr/week
No compensation reported
Avery August
Trustee
On filings since 2019
1 hr/week
No compensation reported
David Driscoll
Trustee
On filings since 2019
1 hr/week
No compensation reported
John Ferretti
Trustee
On filings since 2019
1 hr/week
No compensation reported
John L. Rosenthal
Trustee
On filings since 2019
1 hr/week
No compensation reported
Marc Kramer
Trustee
Chair & Board of Trustees → Chair, 2021
Chair → Trustee, 2022
On filings since 2019
1 hr/week
No compensation reported
Mark Schmidtlein
Trustee
Vice Chair → Vice Chair of Executive Committee, 2021
Vice Chair of Executive Committee → Trustee, 2022
On filings since 2019
1 hr/week
No compensation reported
Owen Garrick
Trustee
On filings since 2019
1 hr/week
No compensation reported
Paul M. Torgerson
Trustee
On filings since 2019
1 hr/week
No compensation reported
Philip J. Falivene
Trustee
On filings since 2019
1 hr/week
No compensation reported
Robert A. Schwartz
Trustee
On filings since 2019
1 hr/week
No compensation reported
Theresa Ragozine
Trustee
On filings since 2019
1 hr/week
No compensation reported
Jaime Shamonki
Trustee
On filings since 2021
1 hr/week
No compensation reported
Jung Choi
Trustee
On filings since 2021
1 hr/week
No compensation reported
Yves Denize
Trustee
On filings since 2021
1 hr/week
No compensation reported
Betsy Jett
Senior Vice President, Quality & Regulatory Affairs
Senior Vice President - Chief Qual & Regulatory Officer → Senior Vice President, Chief Qual & Regulatory Officer, 2022
Senior Vice President, Chief Qual & Regulatory Officer → Senior Vice President, Quality & Regulatory Affairs, 2024
On filings since 2019
50 hrs/week
$414K (2019) → $526K (2025)
Bruce Sachais
Senior Vice President & Chief Medical Officer
Vice President - Chief Medical Officer → Vice President & Chief Medical Officer, 2022
Vice President & Chief Medical Officer → Senior Vice President & Chief Medical Officer, 2024
On filings since 2019
50 hrs/week
$328K (2019) → $451K (2025)
David Graham
Senior Vice President Enterprise Donor Engagement
Vice President - Nybc Divisions → Vp-Nybc Divisions, 2022
Vp-Nybc Divisions → Senior Vice President Enterprise Donor Engagement, 2023
On filings since 2019
50 hrs/week
$248K (2019) → $286K (2025)
Donna Strauss
Senior Vice President & Enterprise Laboratory Services
Vice President - Enterprise Lab Service → Vice President - Enterprise Laboratory Services, 2021
Vice President - Enterprise Laboratory Services → Senior Vice President & Enterprise Laboratory Services, 2025
On filings since 2019
50 hrs/week
$292K (2019) → $189K (2025)
Jordana G. Schwartz
Senior Vice President - General Counsel & Secretary
Senior Vice President, General Counsel & Secretary → Senior Vice President - General Counsel & Secretary, 2020
On filings since 2019
50 hrs/week
$442K (2019) → $90K (2025)
Patricia Killeen
Senior Vice President, Logistics & Ops Excellence
Vp-Ent Blood Ops Optimization → Vice President - Enterprise Blood Operations Optimization, 2021
Vice President - Enterprise Blood Operations Optimization → Senior Vice President, Logistics & Ops Excellence, 2024
On filings since 2019
50 hrs/week
$280K (2019) → $433K (2025)
Monique Brown George
Vice President & Human Resources
Vice President - Human Resources → Vice President & Human Resources, 2024
On filings since 2020
50 hrs/week
$212K (2020) → $334K (2025)
Jeannie Mascolino
Vice President & Blood Operations Nybc
Vice President & Nybc Region Collections → Vice President & Regional Operations, 2024
Vice President & Regional Operations → Vice President & Blood Operations Nybc, 2025
On filings since 2021
50 hrs/week
$311K (2021) → $399K (2025)
Jed Gorlin
Vice President, Medical & Regulatory Affairs
Vice President - Medical & Regulatory Affairs → Vice President, Medical & Regulatory Affairs, 2022
On filings since 2021
50 hrs/week
$355K (2021) → $264K (2025)
Joseph Mohr
Executive Vice President & Chief Business Officer
Chief Financial & Business Officer → Executive Vice President & Chief Business Officer, 2022
On filings since 2021
50 hrs/week
$553K (2021) → $885K (2025)
Larry Luchsinger
Senior Vice President & Chief Scientific Officer
Vice President - Director Research Operations → Senior Vice President & Chief Scientific Officer, 2023
On filings since 2021
50 hrs/week
$165K (2021) → $377K (2025)
Andrea Cefarelli
Executive Vice President & Chief Operating Officer
Senior Vice President & Corporate Communications → Senior Vice President, Corporate Committee & Public Affairs, 2024
Senior Vice President, Corporate Committee & Public Affairs → Executive Vice President & Chief Operating Officer, 2025
On filings since 2022
50 hrs/week
$333K (2022) → $454K (2025)
David Bench
Executive Vice President & Chief Financial Officer
Chief Financial Officer → Executive Vice President & Chief Financial Officer, 2024
On filings since 2022
50 hrs/week
$67K (2022) → $618K (2025)
Eric Senaldi
Deputy Chief Medical Officer
On filings since 2022
50 hrs/week
$309K (2022) → $352K (2025)
Jonathan Barba
Vice President & Information Technology
Vice President Information Technology → Vice President & Information Technology, 2024
On filings since 2022
50 hrs/week
$283K (2022) → $324K (2025)
Mahtab Khan
Vice President of Finance
On filings since 2022
50 hrs/week
$314K (2022) → $341K (2025)
Meghan Wood
Vice President, Ventures & Business Development
On filings since 2022
50 hrs/week
$321K (2022) → $446K (2025)
Adrian David
Executive Vice President & Chief Operating Officer
On filings since 2023
50 hrs/week
$345K (2023) → $385K (2025)
Richard Kiernan
Senior Vice President & Chief Human Resources Officer
On filings since 2023
50 hrs/week
$225K (2023) → $462K (2025)
Vaughn Ratchford
Senior Vice President & Chief Real Estate Officer
On filings since 2023
50 hrs/week
$405K (2023) → $572K (2025)
Shilpi Banerjee
Senior Vice President, General Counsel & Secretary
On filings since 2024
50 hrs/week
$41K (2024) → $419K (2025)
Clay Rich
Senior Vice President, Deputy COO Blood & Lab Operations
New on the 2025 filing
50 hrs/week
$289K (2025)
Eric Gehrie
Deputy Chief Medical Officer
New on the 2025 filing
50 hrs/week
$338K (2025)
Jo Anne Valentino
Senior Vice President Comprehensive Cell Solutions
New on the 2025 filing
50 hrs/week
$359K (2025)
Sarah Vossoughi
Senior Vice President Enterprise Laboratory Services
New on the 2025 filing
50 hrs/week
$174K (2025)
Former officers (36)
- Former: Bernadette Tiso (2019–2024) — Vice President, Deputy General Counsel & Assistant Secretary
- Former: Elizabeth McQuail (2019–2024) — Executive Vice President - Ops, Manufacturing & COO
- Former: Karina Yazdanbakhsh (2021–2024) — Vice President & Director of Research Lfkri
- Former: Shakima Wells (2021–2024) — Senior Associate General Counsel & Assistant Secretary
- Former: Richard Youngblood (2022–2024) — Senior Vice President & Chief of Staff
- Former: Kathryn Geist (2023–2024) — Vice President & Regional Operations
- Former: Devin Blass (2024) — Senior Vice President & Comprehensive Cell Solutions
- Former: Patricia Shi (2024) — Vice President & Medical Director
- Former: Peter Lopez (2019–2023) — Trustee
- Former: Stephen D. Wurtzler (2019–2023) — Trustee
- Former: Barry Greene (2021–2023) — Vice President, Chief Administration Officer Medical & Science
- Former: Tracy Kinjerski (2023) — Vice President & Business Development
- Former: Charles Reppucci (2019–2022) — Trustee
- Former: Mohandas Narla (2019–2022) — Vice President - Lfrki
- Former: Robert Purvis (2019–2022) — Chief of Staff · Filing note: Until 622
- Former: Joon Moon (2020–2022) — Executive Director & Controller Enterprise · Filing note: Until 222
- Former: Debra Kessler (2021–2022) — Vice President - Medical Programs & Services
- Former: Nancy Van Buren (2021–2022) — Associate Medical Director
- Former: Alexandra Jimenez (2022) — Vice President & Medical Director
- Former: Connie Westhoff (2019–2021) — Executive Scientific Director- Immunohematology
- Former: Darlene Folan (2021) — Vice President - Quality Assurance
- Former: Mark Janzen (2021) — Vice President - Laboratory Services
- Former: Beth Shaz MD (2019–2020) — Executive Vice President, Chief Med & Scientifc Ofr
- Former: C. Elizabeth Gibson (2019–2020) — CFO
- Former: Claire Pomeroy (2019–2020) — Trustee
- Former: David Tendler (2019–2020) — Trustee
- Former: Faye Wattleton (2019–2020) — Trustee
- Former: Jennifer Jones-Austin (2019–2020) — Trustee
- Former: Mark Shaw (2019–2020) — Trustee
- Former: Michele Scaggiante (2019–2020) — Vice President - Chief Information Officer
- Former: Pablo Rubinstein (2019–2020) — Vice President - Ncbp
- Former: Thomas Heaney (2019–2020) — Trustee
- Former: Andrew Minkow (2020) — Int CFO
- Former: Christopher Hillyer M. (2020) — President & CEO
- Former: Doriane Gloria (2019) — Vice President - Human Resources
- Former: John Mullen (2019) — Trustee
Data from IRS Form 990 filings, 2019–2025. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2025 IRS filing
The highest reported compensation on the 2025 filing was $2.6M, to Christopher D Hillyer (President & Chief Executive Officer). 26 officers or directors reported compensation on that filing.
Frequently asked questions about New York Blood Center Inc
How large is New York Blood Center Inc?
New York Blood Center Inc reported $865.4M in total assets on its 2025 IRS Form 990. Its revenue that year was $629.0M.
What is New York Blood Center Inc?
New York Blood Center Inc is a public charity focused on Health, based in Rye, NY. It holds $865.4M in total assets as of 2025.
Where does New York Blood Center Inc operate?
New York Blood Center Inc has awarded grants in Maryland.
What is New York Blood Center Inc's EIN?
New York Blood Center Inc's EIN (Employer Identification Number) is 13-1949477. IRS Form 990 filing data is available on this page for 2019–2025.
Data last updated October 2026. Sourced from IRS Form 990 filings.
Here's the math on researching New York Blood Center Inc by hand.
Explore Open Grants
Browse active grant opportunities in New York Blood Center Inc's focus areas in our free grants database
Similar Funders
Similar funders in New York
The Ford Foundation
New York, NY
The Ford Foundation funds organizations, individuals, and ideas working to reduce inequality and advance social justice, including work in areas such as immigrant justice, criminal justice reform, gender equity, and arts and culture, through grants around the world. Its 2024 grants had a median of $100,000, with amounts ranging from $45 to $15 million; it does not accept unsolicited requests by mail, email, or phone.
Assets
$17.5B
Grants
4,007
Total Given
$844.7M
The New York Community Trust
New York, NY
The New York Community Trust funds projects in areas including arts, education, health, human services, community development, and the environment, primarily in New York City, Long Island, and Westchester, with some opportunities elsewhere. Its 2024 median grant was $20,000, though awards varied widely. It accepts applications through its open competitive grants program and selected RFPs or letters of interest; donor-advised funds do not accept proposals.
Assets
$3.5B
Grants
2,748
Total Given
$193.8M
The Simons Foundation Inc
New York, NY
The Simons Foundation funds research in mathematics and the basic sciences, as well as autism and other disease research, through grants to research centers, universities, and related organizations. In 2024, grants ranged from $1,480 to $20 million, with a median of $72,000; funding is concentrated in New York, California, and Massachusetts, with awards also made elsewhere in the U.S. and internationally. Whether it accepts unsolicited requests is not stated.
Assets
$4.5B
Grants
1,727
Total Given
$272.0M
Local Initiatives Support Corporation
New York, NY
Local Initiatives Support Corporation funds affordable housing, economic development, education, health, child care, small businesses and other community initiatives, often through grants, loans and equity. Its 2024 grants had a median of $40,000, with awards ranging from $5,189 to $4.7 million, and its work spans communities across all 50 states. It offers specific grant opportunities, but the profile does not state whether it accepts unsolicited requests generally.
Assets
$1.6B
Grants
1,119
Total Given
$102.8M
Wellspring Philanthropic Fund Inc
New York, NY
Wellspring Philanthropic Fund supports climate and environmental work, human rights, civic engagement, Jewish causes, and some economic-opportunity initiatives, with grants reported across the U.S. and internationally. In 2024, its grants ranged from $500 to $9.75 million, with a median of $200,000. It funds only preselected organizations and does not accept unsolicited requests.
Assets
$134.4M
Grants
1,101
Total Given
$326.0M
More Funders in New York
New York Blood Center Inc down — hundreds of funders to go?